To increase the robustness of our findings, we conducted immunohistochemistry for HNF4A in a validation cohort (UCLA cohort, USA) of 145 tissue specimens from pancreatic cancer patients. This evidence concerns the gene HNF4A and familial pancreatic carcinoma.